Topics
The Retina Pipeline
Targeting Classical Complement Activity in Dry AMD
Sponsored by Annexon Biosciences
View Insert
The New OCULUS CBC Lens
Sponsored by OCULUS Surgical
How to Lighten Your Workload
Editorially independent content supported with advertising by Regeneron and Iveric Bio
View Supplement
The Art & Science of Managing Diabetic Eye Disease
This activity is supported by an unrestricted educational grant from Regeneron.
How Treatments For DR/DME Are Modernizing Medical Retina
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Retina Pipeline 2022: A View Into Ongoing Innovation
Editorially independent content supported by advertising from Genentech
View Interactive Supplement
The Surgical Issue
Survey Findings on Vitreous Opacities and Expert Panel Recommendations on the Referral and Management of Symptomatic Vitreous Opacity Cases
Editorially Independent Content, Supported With Advertising From Alcon Surgical and Heidelberg Engineering
Evolution in Retinal Detachment Surgery
Sponsored by Beaver-Visitec International
Retina Cafe
Sponsored by Iveric Bio
Rebooting the Pathway: Implications for Restoring Complement’s Endogenous Regulator
Sponsored by Gemini
Automated Subretinal Injection: Greater Accuracy, Precision, and Reliability
Sponsored by MedOne Surgical, Inc.
YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg case studies
Diabetic Eye Disease
The Open Secret Behind Iveric Bio’s Continued Success
Themes of Rebirth and Growth are Propelling Samsara Vision Forward
Sponsored by Samsara Vision
Business Matters: Hire Right to Avoid A Fight
Breaking Barriers to Care: Retinal Disease in At-Risk Populations
This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals.
Update on Geographic Atrophy and Complement System–based Therapeutics
This activity is supported by an unrestricted educational grant from Iveric Bio.
Modernizing Medical Retina: Review of the Pipeline
Rare and Inherited Retinal Diseases
Improving the Standard of Care in AMD
Sponsored by Notal Vision
SubLiminal Laser Therapy for CSC
Sponsored by Quantel Medical
EYLEA4U: A Comprehensive Program for EYLEA® (aflibercept) Injection Support
Sponsored by Regeneron
Vitreous Opacities
Clinical Case Compendium
Editorially Independent Content, Supported With Advertising from Bausch + Lomb and NIDEK
Managing the Diabetic Eye: Real-World Strategies for Improving Adherence and Visual Outcomes
Piecing Together the AMD Puzzle
Treatment Adherence in Neovascular AMD
Editorially Independent Content Supported With Advertising From Genentech and Notal Vision
Treating Retinal Disorders: Moving Beyond Anti-VEGF
Supported by an unrestricted educational grant from Genentech
Business Matters: The Benefits of Going Lean
Editorially independent content supported with advertising by Regeneron
Imaging and Visualization Innovation
Diversity and Inclusion
2021 and Beyond: What’s on the Horizon for Wet AMD?
Business Matters: Making the Leap to Private Equity
Editorially independent content supported with advertising by Bausch + Lomb and Regeneron
Update Your Surgical Toolbox
The Art of Drug Choice
Editorially Independent content supported with advertising by Alcon and Novartis
Geographic Atrophy: Insights Into Current Management and Potential Therapies
This activity is supported by an unrestricted educational grant from Apellis Pharmaceuticals.
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
-1_1643042672.jpg?auto=compress,format&w=75)
-1_1638377570.jpg?auto=compress,format&w=75)
